找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 20203rd edition The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr

[复制链接]
查看: 48801|回复: 59
发表于 2025-3-21 19:36:52 | 显示全部楼层 |阅读模式
书目名称Immunotherapy
编辑Aung Naing,Joud Hajjar
视频videohttp://file.papertrans.cn/463/462295/462295.mp4
概述Highlights recent updates in immunotherapeutic strategies to treat patients with solid tumors.Informs on the spectrum of immune-related adverse events.Outlines strategies to overcome challenges associ
丛书名称Advances in Experimental Medicine and Biology
图书封面Titlebook: Immunotherapy;  Aung Naing,Joud Hajjar Book 20203rd edition The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr
描述.Immunotherapy is a rapidly evolving field that mandates frequent revision of the book as new insights to fight cancer emerge. The third edition of .Immunotherapy. is an updated overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. It explores the breath of immunotherapeutic strategies available to treat a wide range of cancers, from melanoma and non-small cell lung cancer to gastrointestinal, genitourinary, gynecologic and nervous system malignancies. With increasing use of checkpoint inhibitors as standard of care and in clinical trials, the challenges associated with their use undoubtedly increase. As objective response is limited to a subset of patients and is often associated with distinct immune related side effects that are potentially life threatening, it is essential to identify patients who are likely to respond to immunotherapy and those who are at a risk for developing treatment-related side effects. In the absence of a validated predictive biomarker, innovative technologies and assays are being used to identify critical biomarkers that drive the immune response. Hence, a chapter to provide a basic understanding of the diagn
出版日期Book 20203rd edition
关键词translational cancer immunology; vaccine; il-10; immune-oncology; tumor immunology; immune-therapy; immune
版次3
doihttps://doi.org/10.1007/978-3-030-41008-7
isbn_ebook978-3-030-41008-7Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Immunotherapy影响因子(影响力)




书目名称Immunotherapy影响因子(影响力)学科排名




书目名称Immunotherapy网络公开度




书目名称Immunotherapy网络公开度学科排名




书目名称Immunotherapy被引频次




书目名称Immunotherapy被引频次学科排名




书目名称Immunotherapy年度引用




书目名称Immunotherapy年度引用学科排名




书目名称Immunotherapy读者反馈




书目名称Immunotherapy读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:27:34 | 显示全部楼层
发表于 2025-3-22 02:09:31 | 显示全部楼层
发表于 2025-3-22 04:55:56 | 显示全部楼层
发表于 2025-3-22 11:03:56 | 显示全部楼层
发表于 2025-3-22 15:58:11 | 显示全部楼层
发表于 2025-3-22 20:15:45 | 显示全部楼层
发表于 2025-3-22 21:48:43 | 显示全部楼层
发表于 2025-3-23 04:01:14 | 显示全部楼层
Mingxuan Xu,Ilgin Ergin,Semir Beyazre. ” In the 1960s and subsequent decades, the clinical During life, there exist phases of age-related c- and immunological aspects of immune deficiencies were promised immune functions. After birth there is a phys- studied and adequate treatment attempted. A reflection of logical immune deficiency because th978-0-306-47527-6
发表于 2025-3-23 05:52:48 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-15 12:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表